Novavax, Inc. (NVAX) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 5 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
blas.soto blas.soto 03/13/2014 1 day $5.37 $5.37 no change 0 Ended
Comments:
thomasbgray thomasbgray 03/07/2014 3 months $6.05 $4.17 -31.07% -31 Active
Comments: They are about to explode!
Kimberly_29 Kimberly_29 01/28/2014 1 Year $5.81 $4.17 -28.23% -28 Active
Comments:
petrux petrux 01/25/2014 3 months $6.25 $4.17 -33.28% -33 Active
Comments:
NicolasCaridi NicolasCaridi 01/24/2014 3 months $6.25 $4.17 -33.28% -33 Active
Comments: undervalued
Steve57 Steve57 01/19/2014 3 months $6.13 $4.03 -34.26% -34 Ended
Comments: stock is undervalued and has a strong management
TimJohnsey TimJohnsey 01/08/2014 3 months $5.16 $4.10 -20.54% -20 Ended
Comments: The positive upturn of the company will only grow for investors.
chaschee chaschee 12/03/2013 3 months $3.85 $6.40 +66.23% 66 Ended
Comments: wide range of posible vaccines.
Kreuz55 Kreuz55 12/02/2013 3 months $3.95 $6.40 +62.03% 62 Ended
Comments:
Daniel.Caridi Daniel.Caridi 11/13/2013 1 month $2.91 $3.95 +35.74% 35 Ended
Comments:
doingthedd2014 doingthedd2014 11/11/2013 3 months $2.95 $5.34 +81.02% 81 Ended
Comments: This is a well managed company
jamaican jamaican 05/10/2013 1 Year $2.16 $4.17 +93.06% 93 Active
Comments: Leading position on RSV Vaccine using latest Virus Like Particle (VLP) and also pandemic flu.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.